中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
MFAP2 aggravates tumor progression through activating FOXM1/beta-catenin-mediated glycolysis in ovarian cancer

文献类型:期刊论文

作者Zhao, Ling-Qin1,2; Sun, Wei1,2; Zhang, Ping1,2; Gao, Wen1,2; Fang, Chen-Yan1,2; Zheng, Ai-Wen1,2
刊名KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
出版日期2022-05-12
关键词CCK-8 FOXM1 GLUT1 microfibril-associated protein 2 (MFAP2) ovarian cancer
ISSN号1607-551X
DOI10.1002/kjm2.12546
通讯作者Zheng, Ai-Wen(zhengaiwen12345@163.com)
英文摘要Ovarian cancer is one of the most common gynecological tumors that seriously endanger the health and quality of life of women. Microfibril-associated protein 2 (MFAP2) has been demonstrated to play crucial roles in the development of multiple tumors. However, the function of MFAP2 in ovarian cancer remains unclear. In this study, we found that MFAP2 was upregulated in ovarian cancer and cells and was positively correlated with FOXM1 and glycolysis-related genes. The results of Cell Count Kit-8, colony formation, and flow cytometry assays indicated that MFAP2 promoted cell proliferation. In addition, MFAP2 promotes cell proliferation, glucose uptake, lactate production; increases ATP levels, extracellular acidification ratio, and oxygen consumption ratio in ovarian cancer cells and increases the expression of glycolytic proteins. Further mechanistic analysis suggests that MFAP2 promotes FOXM1/beta-catenin-mediated glycolysis signaling in ovarian cancer cells. Knockdown of MFAP2 inhibits ovarian cancer xenograft tumor growth and expression of Ki-67, MFAP2, FOXM1, GLUT1, HK2, and beta-catenin in mice. In conclusion, MFAP2 promotes cell proliferation and glycolysis by modulating the FOXM1/beta-catenin signaling pathway in ovarian cancer, which may offer a fresh insight into the treatment of ovarian cancer in the glycolysis pathway.
WOS关键词GASTRIC-CANCER ; FOXM1 PROMOTES ; MICROFIBRILS ; METASTASIS ; METABOLISM ; BIOMARKERS ; CELLS
资助项目Medical Science Project of Zhejiang Province[2022KY688]
WOS研究方向Research & Experimental Medicine
语种英语
WOS记录号WOS:000793718700001
出版者WILEY
资助机构Medical Science Project of Zhejiang Province
源URL[http://ir.hfcas.ac.cn:8080/handle/334002/130821]  
专题中国科学院合肥物质科学研究院
通讯作者Zheng, Ai-Wen
作者单位1.Chinese Acad Sci, Inst Basic Med & Canc IBMC, Hangzhou, Peoples R China
2.Univ Chinese Acad Sci, Canc Hosp, Dept Gynecol Oncol, Zhejiang Canc Hosp, East Banshan Rd, Hangzhou 310022, Peoples R China
推荐引用方式
GB/T 7714
Zhao, Ling-Qin,Sun, Wei,Zhang, Ping,et al. MFAP2 aggravates tumor progression through activating FOXM1/beta-catenin-mediated glycolysis in ovarian cancer[J]. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES,2022.
APA Zhao, Ling-Qin,Sun, Wei,Zhang, Ping,Gao, Wen,Fang, Chen-Yan,&Zheng, Ai-Wen.(2022).MFAP2 aggravates tumor progression through activating FOXM1/beta-catenin-mediated glycolysis in ovarian cancer.KAOHSIUNG JOURNAL OF MEDICAL SCIENCES.
MLA Zhao, Ling-Qin,et al."MFAP2 aggravates tumor progression through activating FOXM1/beta-catenin-mediated glycolysis in ovarian cancer".KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2022).

入库方式: OAI收割

来源:合肥物质科学研究院

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。